Clinical Laboratory Disease Reporting and Specimen Submission Requirements
For more information, contact the Epidemiology Unit at (619) 692-8499 or the Public Health Laboratory at (858) 325-6400.
This page outlines how and when laboratories must report specific diseases to the San Diego County of San Diego Public Health Laboratory, per the Title 17, California Code of Regulations Section 2505.
- This includes local requirements for submitting specimens and
laboratory test results suggestive of diseases of public health
importance to the local health department.
- Laboratory findings for these diseases are those that satisfy the most recent communicable disease surveillance case definitions established by the Centers for Disease Control and Prevention (CDC), unless otherwise specified.
All laboratory notifications are acquired in confidence. The confidentiality of patient information is always protected.
On this page:
Laboratory reports must be made in writing and give the following information:
- Date the specimen was obtained.
- Patient identification number.
- Specimen accession number or another unique specimen identifier.
- Specimen Sites.
- Diagnosis Code(s).
- Laboratory findings for the test performed.
- Date that any positive laboratory findings were identified.
- Name, gender, address, telephone number (if known), pregnancy status, race, ethnicity, and date of birth of the person from whom the specimen was obtained.
- Name, address, and telephone number of the health care provider who ordered the test.
Submit this information via a laboratory report or by completing a Confidential Morbidity Report (CMR). Please attach the laboratory report to the CMR.
Laboratories must report certain findings/diseases to the local health officer based on where the patient lives by fax or electronic reporting. The timing depends on the disease.
-
Subsection (e)(1) (urgent diseases):
- Call within one (1) hour of confirming a positive result.
- Follow-up with a written report, sent via fax or e-mail, within one (1) working day.
- Subsection (e)(2)
(all other reportable diseases):
- Send a written report within one (1) working day of confirming a positive result.
Who Should Report
The report must be made from the time that the laboratory notifies that health care provider or other person authorized to receive the report.
- If a laboratory found the positive result, they must report it – even if the specimen came from another laboratory.
- If a laboratory received the specimen from another laboratory, report the result within the required timeframe, starting from when the referring laboratory was notified.
- If the laboratory is out-of-state, and results are sent to a California laboratory, the California laboratory must report the case as if it made the finding.
Specimen Transfers
- If a specimen or isolate is
sent from one laboratory to another, it must be accompanied by a
test request form that includes:
- Patient information, and
- Submitter information (provider or facility name that ordered the test).
- The first laboratory that receives the specimen is responsible for collecting and including this information.
Immediate Report – Subsection (e)(1)
For certain urgent diseases, laboratories must call the following within one (1) hour to report a suspected case.
-
California Department of Public Health (CDPH) Infectious
Disease Laboratory Branch: (510) 620-3434.
- Viral and Rickettsial Disease Lab (VRDL): (510) 307-8585 (for influenza-novel strains, Smallpox, or Viral Hemorrhagic Fevers.
-
County of San Diego:
- Epidemiology Unit: (619) 692-8499; After Hours: (858) 565-5255.
- Public Health Laboratory: (858) 325-6400.
Follow-up with a written report, sent via fax or e-mail, within one (1) working day.
Disease/Microorganism | Submit to Public Health Lab |
Anthrax, animal (B. anthracis) | N/A |
Anthrax, human (B. anthracis) | Suspect isolate |
Botulism | Diagnostic specimens: · Serum: 15 mL · Feces: 10-25 grams · Food: Entire food specimen · Gastric aspirate/vomitus: 20 mL Wound: Entire piece of surgically debrided tissue or volume of wound aspirate; swab with anaerobic transport medium used for deep wound sampling is acceptable. · Cultures: ≥10 ml of enriched broth culture |
Brucellosis, human (all Brucella spp.) | Suspect isolate |
Burkholderia pseudomallei and B. mallei (detection or isolation from a clinical specimen) | Suspect isolate |
Influenza, novel strains (human) |
Respiratory specimen in VTM |
Plague, animal | N/A |
Plague, human | Suspect isolate |
Smallpox (Variola) | Scab, scab fluid, dry/wet swab of lesion |
Tularemia, human (F. tularensis) | Suspect isolate |
Viral hemorrhagic fever agent, human (VHF) (e.g., Crimean-Congo, Ebola, Lassa, and Marburg viruses) | Serum |
Subsection (e)(2) List – Report to the Epidemiology Unit via Fax to (858) 715-6458.
Disease/Microorganism | Submit to Public Health Lab |
Acid-fast bacillus** | N/A |
Anaplasmosis | N/A |
Babesiosis | N/A |
Bordetella pertussis acute infection, by culture or molecular identification | N/A |
Borrelia burgdorferi infection | N/A |
Brucellosis, animal (Brucella spp. except Brucella canis) | N/A |
Campylobacteriosis (Campylobacter spp.) (detection or isolation from a clinical specimen) |
N/A |
Candida auris, colonization or infection** |
Isolate |
Carbapenemase-producing organism, colonization or infection | Isolate if requested by HAI Epidemiology Unit |
Chancroid (Haemophilus ducreyi) | N/A |
Chikungunya Virus infection | Serum |
Coccidioidomycosis | N/A |
Cronobacter sakazakii in infants less than one year of age | Isolate |
Cryptosporidiosis | N/A |
Cyclosporiasis (Cyclospora cayetenensis) | N/A |
Dengue virus infection | serum |
Diphtheria | N/A |
Ehrlichiosis | N/A |
Encephalitis, arboviral | N/A |
Escherichia coli infection: shiga toxin producing (STEC), including E. coli O157 | Isolate(s), GN, or MAC broth as soon as available |
Flavivirus infection of undetermined species |
|
Giardiasis (Giardia lamblia, intestinalis, or duodenalis) | N/A |
Haemophilus influenzae infection, all types (detection or isolation from a sterile site in a person less than five years of age) | Isolate if requested by Immunization Unit · For diagnosis, ≥ 0.5 mL CSF, EDTA whole blood, blood culture bottle media, and/or pleural fluid on cold pack |
Hantavirus Infections | Serum |
Hepatitis A, acute infection | N/A |
Hepatitis B, acute or chronic infection (specify gender) | N/A |
Hepatitis C, acute or chronic infection | N/A |
Hepatitis D (Delta), acute or chronic infection | N/A |
Hepatitis E, acute infection (detection of hepatitis E virus RNA from a clinical specimen or positive serology) | N/A |
Human Immunodeficiency Virus (HIV), acute infection |
|
Influenza |
|
Legionellosis (Legionella spp.) (antigen or culture) | Isolate |
Leprosy (Hansen Disease) (Mycobacterium leprae) | N/A |
Leptospirosis (Leptospira spp.) | N/A |
Listeriosis (Listeria) | Isolate as soon as available |
Malaria** (Plasmodium spp.) |
Thick and thin stained blood smears, ≥ 0.5 mL EDTA whole blood (“purple top” tube) transported on cold pack. Send immediately. |
Measles (Rubeola), acute infection |
Serum, urine, NP |
Middle East Respiratory Syndrome Coronavirus (MERS-CoV), infection |
|
Monkeypox or orthopox virus infection |
|
Mumps (mumps virus), acute infection |
Serum |
Neisseria meningitidis (sterile site isolate or eye specimen) infection | Isolate or eye specimen as soon as available · For diagnosis, ≥ 0.5 mL CSF, EDTA whole blood, blood culture bottle media, and/or pleural fluid on cold pack |
Poliovirus infection | N/A |
Psittacosis (Chlamydophila psittaci) | N/A |
Q Fever (Coxiella burnetii) |
whole blood and serum |
Rabies, animal or human | N/A |
Relapsing Fever (Borrelia spp.) (identification of Borrelia spp. spirochetes on peripheral blood smear) | N/A |
Respiratory syncytial virus |
|
Rickettsia, any species, acute infection (detection from a clinical specimen or positive serology) | N/A |
Rocky Mountain Spotted Fever (Rickettsia rickettsii) | N/A |
Rubella, acute infection | N/A |
Salmonellosis (Salmonella spp.) | Isolate as soon as available |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
|
Shiga toxin (detected in feces) | Isolate(s), GN, or MAC broth as soon as available |
Shigellosis (Shigella spp.) |
Isolate as soon as available |
Trichinosis (Trichinella) | N/A |
Tularemia, animal (F. tularensis) | N/A |
Typhoid | Isolate |
Vibrio cholerae, V. parahaemolyticus, Vibrio if unable to speciate | Isolate; specimen positive by culture independent test |
West Nile virus infection | CSF, serum |
Yellow Fever (yellow fever virus) | Serum |
Yersiniosis (Yersinia spp., non-pestis) (isolation from a clinical specimen) | Isolate |
Zika virus infection |
|
Subsection (e)(2) List – Report to the HIV, STD, and Hepatitis Branch STD Program via Fax to (619) 692-8541, or Secure Email to phs-hshb-stdreporting-fax.hhsa@sdcounty.ca.gov.
Disease/Microorganism | Submit to Public Health Lab |
Chlamydia trachomatis infections, including lymphogranuloma venereum | N/A |
Gonorrhea, Neisseria gonorrhoeae with resistance or decreased susceptibility to ceftriaxone or cefixime | Isolate, as soon as possible |
Syphilis | N/A |
Subsection (e)(2) List – Report to Tuberculosis Control and Refugee Health via Fax to (619) 692-5516.
Disease/Microorganism | Submit to Public Health Lab |
Mycobacterium tuberculosis complex** | Isolate, as soon as possible |
**See Additional Reporting Requirements.
N/A: Not applicable.
Malaria
If a clinical laboratory identifies malaria parasites in a
patient’s blood smear:
- The laboratory must immediately send one or more blood film slides (and an EDTA blood tube, if available) to the local public health laboratory in the jurisdiction where the patient lives.
- Upon request, all submitted blood slides will return to the original sender.
Salmonella
Per California
Code of Regulations, Title 17, Section 2612, if a
laboratory confirms a diagnosis of salmonellosis, the culture of the
organism must be:
- Submitted to the local public health laboratory; and
- Forwarded to the California Department of Public Health’s Microbial Diseases Laboratory (MDL) for final identification.
Tuberculosis (TB) and Acid-Fast Bacillus (AFB)
If a laboratory isolates Mycobacterium tuberculosis or
identifies the Mycobacterium tuberculosis complex by molecular
testing from a patient specimen, the culture must be submitted to the
local public health laboratory for the jurisdiction where the patient lives.
- This should be done as soon as the primary isolate (used for TB diagnosis) becomes available.
- If a culture isolate is not available, the laboratory must submit a specimen that is available.
- The submission must include all the required information listed in the section “How to Report”.
- The San Diego County of San Diego Public Health Laboratory will keep one culture (per culture-positive patient) in a viable state for at least six (6) months.
Drug Susceptibility Testing:
Unless testing has already been done within the past three (3) months by the same or another laboratory, the clinical laboratory must do the following:
- Perform or refer for drug susceptibility testing on at least one (1) isolate per patient with Mycobacterium tuberculosis;
- Report the results of susceptibility testing, including molecular assays for drug resistance if performed, to the local health officer (in the patient’s jurisdiction) within one (1) working day of notifying the healthcare provider or authorized person who submitted the specimen; and
- If drug susceptibility testing determines the culture to
be resistant to both isoniazid and rifampin (i.e.,
multidrug-resistant Mycobacterium tuberculosis complex), the
laboratory must also submit one culture or subculture from that
patient to the local public health lab as soon as possible.
- The San Diego County Public Health Laboratory will forward it to the CDPH Microbial Diseases Laboratory.
Additional AFB Testing Requirement:
If a patient with suspected or confirmed tuberculosis tests positive for AFB on a specimen and has not had a culture identifying the organism in the past 30 days, the laboratory must:
- Culture and identify the AFB organism, or
- Send a subculture to another laboratory.
Subsection (m)(2) List, Submission to Public Health Laboratory
- Drug resistant Neisseria gonorrhoeae isolates (cephalosporin or azithromycin only)
- Listeria monocytogenes isolates
- Mycobacterium tuberculosis isolates (see Tuberculosis)
- Neisseria meningitidis isolates from sterile sites
- Salmonella isolates (see Salmonella)
- Shiga toxin-producing Escherichia coli (STEC) isolates, including O157 and non-O157 strains
- Shigella isolate
If a laboratory test result indicates infection with any one of the pathogens listed in (m)(2), the testing laboratory must attempt to obtain a bacterial culture isolate for submission to a public health laboratory in accordance with (m)(2). This requirement includes identification cases of where Shiga toxin is found in a clinical specimen. If latent tuberculosis infection is identified, an attempt to obtain a bacterial culture isolate is not required. The testing laboratory shall take necessary steps to obtain an isolate, including requesting the collection of additional specimens and promptly sending specimens to a laboratory capable of performing bacterial culture.
Subsection (r): Instructions for Submission of Candida auris isolates to Public Health Laboratory
If a Candida auris isolate(s) is identified from a sterile site, and the laboratory has obtained a fungal culture isolate, the isolate(s) must be submitted to a public health laboratory within ten (10) working days from the date the specimen was collected.
The following information should be submitted with the specimen:
- Name, address, and date of birth of the person from whom the specimen was obtained.
- Patient identification number.
- Isolate or specimen accession number or other unique identifier.
- Date the isolate or specimen was obtained from the patient.
- Name, address, and telephone number and laboratory director’s name of the laboratory submitting the isolate or specimen.
- Appropriate form (see Form List).
- Special forms are required
to be submitted for testing of the following diseases:
- Avian Influenza
- Botulism
- Hantavirus
- Influenza (Seasonal and 2009 Pandemic H1N1)
- Hepatitis E
- Malaria
- Smallpox
- West Nile Virus
- Special forms are required
to be submitted for testing of the following diseases:
Contact the San Diego County Public Health Laboratory at (858) 325-6400 to obtain forms.
Form List
- Confidential Morbidity Report
- Adult C. botulinum Toxin Detection Laboratory Request and Final Report Form
- Avian Influenza A (H5N1) Submittal Form
- CDC DASH Form 50.34
- Chlamydia/Gonorrhea Examination Form
- Chlamydia/Gonorrhea Examination Form (Juvenile Hall)
- Gonorrhea Culture Requisition Form
- Hepatitis Serology Form
- HIV Court Order Form
- HIV-1 Antibody Test Request Form
- Influenza Virus Culture Request Form
- Influenza Virus PCR Requisition Form (Seasonal and 2009 Pandemic H1N1)
- Interfering Substances with Botulism Testing
- Molecular Test Request Form
- Mycobacteria (TB) CI Form
- Mycobacteria (TB) Culture Form
- Public Health Laboratory Test Requisition Form (10/11/24)
- Quantiferon In-tube Lab Request Form
- Serologic Examination Form
- Smallpox Sample Submission Form
- Syphilis Serology Form
- Virus Isolation Request Form
- West Nile Virus Specimen Submittal Form
Packaging and Shipping Information
All specimens submitted to the San Diego County Public Health Laboratory must comply with all applicable U.S. Postal Service, DOT or IATA requirements (i.e., packaged, labeled and documented, as per applicable regulations).
- San Diego County Public Health Laboratory:
- Phone Number: (858) 325-6400
- Fax Number: (858) 268-4102
- Mailing Address (with Mail Stop):
San Diego County Public Health Laboratory
5540 Overland Avenue
San Diego, CA 92123
MS P572
- County of San Diego:
- CDPH:
- CDC:



